Skip to main content
. 2020 Feb;8(2):182–191. doi: 10.1016/S2213-2600(19)30367-4

Table 5.

Patients with reported adverse events or serious adverse events

Biomarker-guided recommendation on antibiotics group (n=103) Routine use of antibiotics group (n=106)
Adverse event or serious adverse event reported 43 (42%) 37 (35%)
Adverse event recorded 39 (91%) 35 (95%)
Serious adverse event recorded 4 (9%) 2 (5%)

Data are number of patients (%); multiple events were reported in some patients.